MedDataX Logo

Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis

NCT ID: NCT01680263

Last Updated: 2012-09-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-02-29

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to determine the effects of kinesiotaping in comparison to NSAIDs and physical therapy in treatment of pes anserinus tendino-bursitis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The treatment of pes anserinus tendino-bursitis includes refraining from aggravating activities, local modalities such as heat, ice, ultrasound (US), iontophoresis, phonophoresis, electrical stimulation (ES), nonsteroidal anti-inflammatory drugs (NSAIDs) and injections with either corticosteroids or local anesthetics. Another treatment that seems to have a significant effect on the improvement of the disease is kinesiotaping. Kinesiotaping is a cotton strip with an acrylic adhesive that is used for treating athletic injuries and a variety of physical conditions. The therapeutic effects of the tape is to relax the overused muscles and in rehabilitation to facilitate the underused muscles. Advocates claim that the wave pattern found on the kinesiotaping has a lifting effect on the skin which can diminish swelling and inflammation via improving circulation and reduce pain by removing pressure from pain receptors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pes Anserinus Tendinobursitis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Kinesiotaping pes anserinus tendino-bursitis nonsteroidal anti-inflammatory drugs physical therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Kinesiotaping

Use of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1 week interval

Group Type EXPERIMENTAL

Kinesiotaping

Intervention Type DEVICE

Use of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1week interval

NSAIDs/Physical therapy

treatment was done with NSAIDs and 10 sessions of daily physical therapy.

Group Type ACTIVE_COMPARATOR

NSAIDs/Physical therapy

Intervention Type PROCEDURE

Use of non-steroidal anti-inflammatory drugs and 10 sessions of daily physical therapy.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kinesiotaping

Use of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1week interval

Intervention Type DEVICE

NSAIDs/Physical therapy

Use of non-steroidal anti-inflammatory drugs and 10 sessions of daily physical therapy.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

taping non-steroidal anti-inflammatory drugs physical therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with clinical diagnosis of pes anserinus tendino-bursitis.

Exclusion Criteria

* Previous history of trauma or surgery on the knee joint,
* History of NSAIDs induced acid-peptic disease
* Systemic and rheumatic diseases
Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shiraz University of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kaynoosh Homayouni

Assistant professor of Physical Medicine and Rehabilitation

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kaynoosh Homayouni, M.D.

Role: STUDY_CHAIR

Shiraz University of Medical Sciences

Shima Foruzi, M.D.

Role: PRINCIPAL_INVESTIGATOR

Shiraz University of Medical Sciences

Fereshte Kalhori, M.D.

Role: PRINCIPAL_INVESTIGATOR

Shiraz University of Medical Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shiraz University of Medical Sciences

Shiraz, Fars, Iran

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Iran

References

Explore related publications, articles, or registry entries linked to this study.

Homayouni K, Foruzi S, Kalhori F. Effects of kinesiotaping versus non-steroidal anti-inflammatory drugs and physical therapy for treatment of pes anserinus tendino-bursitis: A randomized comparative clinical trial. Phys Sportsmed. 2016 Sep;44(3):252-6. doi: 10.1080/00913847.2016.1199251. Epub 2016 Jun 22.

Reference Type DERIVED
PMID: 27276165 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

K Homayouni

Identifier Type: -

Identifier Source: org_study_id